Sarilumab Administration in COVID-19 Patients: Literature Review and Considerations

Sarilumab Administration in COVID-19 Patients: Literature Review and Considerations

Two years have passed since WHO declared a pandemic state for SARS-CoV-2 infection. COVID-19 pathogenesis consists of a first viral phase responsible for early symptoms followed by an inflammatory phase, cytokine-mediated, responsible for late-onset manifestations up to ARDS. The dysregulated immune...

Full description

Bibliographic Details
Main Authors: Andrea Marino, Antonio Munafò, Egle Augello, Carlo Maria Bellanca, Carmelo Bonomo, Manuela Ceccarelli, Nicolò Musso, Giuseppina Cantarella, Bruno Cacopardo, Renato Bernardini
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Infectious Disease Reports
Subjects:
COVID-19
cytokines
IL-6
IL-6R
sarilumab
Online Access:https://www.mdpi.com/2036-7449/14/3/40

Similar Items

Similar Items